HVC KYOTO Announces 12 Finalists for 2026 Demo Day
Key facts
- HVC KYOTO Announces 12 Finalists for 2026 Demo Day
- HVC KYOTO, a healthcare innovation platform, has selected 12 finalists for its upcoming Demo Day on July 13-14, 2026. The event will feature pitches, keynotes, and 3 startups from the UK.
- Source: PR Times
- Date: June 5, 2026
Direct answer
HVC KYOTO, a healthcare innovation platform, has selected 12 finalists for its upcoming Demo Day on July 13-14, 2026. The event will feature pitches, keynotes, and 3 startups from the UK.
- Citation
- HVC KYOTO Announces 12 Finalists for 2026 Demo Day (June 5, 2026), PR Times
- Source
- PR Times
- Date
- June 5, 2026
HVC KYOTO, a healthcare innovation platform, has selected 12 finalists for its upcoming Demo Day on July 13-14, 2026. The event will feature pitches, keynotes, and 3 startups from the UK.
📋 Article Processing Timeline
- 📰 Published: June 5, 2026 at 10:00
- 🔍 Collected: June 5, 2026 at 10:26 (26 min after Published)
- 🤖 AI Analyzed: June 6, 2026 at 17:50 (31h 23m after Collected)
HVC KYOTO, an innovation platform supported by JETRO, the Kyoto Prefectural Government, Kyoto City, and Kyoto Research Park (KRP) to assist cross-border healthcare business development, has selected 12 finalists for the HVC Demo Day to be held over July 13–14, 2026. The finalist pitch on the second day will be open to the general public via advance registration.
Event Overview:
- Name: HVC KYOTO (Healthcare Venture Conference Kyoto) 2026 Demo Day
- Dates: July 13 (Mon) Day 1 (Business meetings, Reception), July 14 (Tue) Day 2 (Finalist pitches, Keynote)
- Venue: Buzz Hall, B1F, KRP Building 4
- Activities: Pitches, Keynotes by domestic and international experts, Networking
In addition to the 12 finalists, three startups from the UK are scheduled to present: Argonaute RNA Ltd. (Biotech), Impli Health (MedTech), and Neubond Ltd. (MedTech).
HVC provides growth opportunities for seed to early-stage startups, having selected 194 startups over the past 10 years and facilitating over 83 billion JPY in cumulative funding. In February 2025, it received the 'Minister of Economy, Trade and Industry Award' at the 7th Japan Open Innovation Prize.
Event Overview:
- Name: HVC KYOTO (Healthcare Venture Conference Kyoto) 2026 Demo Day
- Dates: July 13 (Mon) Day 1 (Business meetings, Reception), July 14 (Tue) Day 2 (Finalist pitches, Keynote)
- Venue: Buzz Hall, B1F, KRP Building 4
- Activities: Pitches, Keynotes by domestic and international experts, Networking
In addition to the 12 finalists, three startups from the UK are scheduled to present: Argonaute RNA Ltd. (Biotech), Impli Health (MedTech), and Neubond Ltd. (MedTech).
HVC provides growth opportunities for seed to early-stage startups, having selected 194 startups over the past 10 years and facilitating over 83 billion JPY in cumulative funding. In February 2025, it received the 'Minister of Economy, Trade and Industry Award' at the 7th Japan Open Innovation Prize.
FAQ
What is the goal of HVC KYOTO?
Its goal is to support the growth of innovative businesses by providing healthcare startups with opportunities for business partnerships and funding.
What kind of companies participate as partners?
A diverse range of companies and organizations participate, including pharmaceutical companies, medical device manufacturers, VCs, universities, and research institutions.
What are the achievements of past participants?
Past participants have achieved significant successes, such as opening overseas offices, large-scale business partnerships, J-Startup certification, and AMED funding.